Exam 1: Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease

doi:10.1016/j.cgh.2021.11.025

Exam 1: Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2021.11.025 ◽

2022 ◽

Vol 20 (2) ◽

pp. e337-e338

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonists ◽

Serious Infections ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Risk of serious infections with vedolizumab versus tumor necrosis factor antagonists in patients with inflammatory bowel disease

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2020.12.030 ◽

2020 ◽

Author(s):

Julien Kirchgesner ◽

Rishi J. Desai ◽

Laurent Beaugerie ◽

Sebastian Schneeweiss ◽

Seoyoung C. Kim

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonists ◽

Serious Infections ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732092122.793568144 ◽

2019 ◽

Author(s):

Ashish Patel

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

JAMA ◽

10.1001/jama.2017.16071 ◽

2017 ◽

Vol 318 (17) ◽

pp. 1679 ◽

Cited By ~ 176

Author(s):

Magali Lemaitre ◽

Julien Kirchgesner ◽

Annie Rudnichi ◽

Fabrice Carrat ◽

Mahmoud Zureik ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2012.06.032 ◽

2012 ◽

Vol 10 (10) ◽

pp. 1079-1087 ◽

Cited By ~ 142

Author(s):

Ingrid Ordás ◽

Brian G. Feagan ◽

William J. Sandborn

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Therapeutic Drug Monitoring ◽

Bowel Disease ◽

Drug Monitoring ◽

Tumor Necrosis ◽

Therapeutic Drug ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2016.06.025 ◽

2017 ◽

Vol 15 (1) ◽

pp. 25-36.e27 ◽

Cited By ~ 57

Author(s):

Laurent Peyrin-Biroulet ◽

Gert Van Assche ◽

David Gómez-Ulloa ◽

Laura García-Álvarez ◽

Núria Lara ◽

...

Keyword(s):

Systematic Review ◽

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Extraintestinal Manifestations ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Patterns of steroid and steroid sparing regimens among older inflammatory bowel disease (IBD) patients with contraindications to tumor necrosis factor antagonists (ANTI-TNFS)

Value in Health ◽

10.1016/j.jval.2014.03.243 ◽

2014 ◽

Vol 17 (3) ◽

pp. A40

Author(s):

S.L. Johnson ◽

C. Bartels ◽

C. Thorpe ◽

M. Palta ◽

J. Weiss ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Necrosis Factor ◽

Steroid Sparing

Download Full-text

Sa1872 IMMUNOGENICITY OF TUMOR NECROSIS FACTOR ANTAGONISTS AND THE EFFECT OF DOSE ESCALATION TO IMPROVE DRUG CONCENTRATIONS AND ELIMINATE ANTIBODIES IN A LARGE INFLAMMATORY BOWEL DISEASE POPULATION

Gastroenterology ◽

10.1016/s0016-5085(20)31831-x ◽

2020 ◽

Vol 158 (6) ◽

pp. S-459-S-460

Author(s):

Robert Battat ◽

Ellen J. Scherl ◽

Suresh Pola ◽

Dana J. Lukin ◽

Anand Kumar ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Dose Escalation ◽

Bowel Disease ◽

Tumor Necrosis ◽

Drug Concentrations ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2017.02.005 ◽

2017 ◽

Vol 15 (9) ◽

pp. 1359-1372.e6 ◽

Cited By ~ 24

Author(s):

Yun Qiu ◽

Ren Mao ◽

Bai-li Chen ◽

Sheng-hong Zhang ◽

Jing Guo ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Combination Therapy ◽

Bowel Disease ◽

Tumor Necrosis ◽

Meta Analysis ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Trough Levels ◽

Necrosis Factor

Download Full-text

Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease

Journal of Clinical Gastroenterology ◽

10.1097/mcg.0000000000000758 ◽

2017 ◽

Vol 51 (5) ◽

pp. 394-401 ◽

Cited By ~ 9

Author(s):

Tushar Shukla ◽

Siddharth Singh ◽

Parul Tandon ◽

Jeffrey D. McCurdy

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Cytomegalovirus Reactivation ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2017.01.035 ◽

2017 ◽

Vol 15 (7) ◽

pp. 1061-1070.e1 ◽

Cited By ~ 11

Author(s):

Laura E. Targownik ◽

Aruni Tennakoon ◽

Stella Leung ◽

Lisa M. Lix ◽

Harminder Singh ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Temporal Trends ◽

Population Based ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Initiation Of Therapy ◽

Necrosis Factor

Download Full-text